Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Kraig Biocraft Laboratories (KBLB) Total Current Liabilities (2016 - 2022)

Kraig Biocraft Laboratories (KBLB) has disclosed Total Current Liabilities for 11 consecutive years, with $8.7 million as the latest value for Q3 2022.

  • Quarterly Total Current Liabilities fell 3.71% to $8.7 million in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $8.7 million through Sep 2022, down 3.71% year-over-year, with the annual reading at $8.2 million for FY2021, N/A changed from the prior year.
  • Total Current Liabilities hit $8.7 million in Q3 2022 for Kraig Biocraft Laboratories, down from $9.1 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $9.1 million in Q2 2022 to a low of $3.7 million in Q1 2018.
  • Historically, Total Current Liabilities has averaged $6.5 million across 4 years, with a median of $6.4 million in 2019.
  • Biggest five-year swings in Total Current Liabilities: rose 29.81% in 2018 and later fell 3.71% in 2022.
  • Year by year, Total Current Liabilities stood at $4.5 million in 2018, then grew by 8.23% to $4.9 million in 2019, then surged by 66.46% to $8.2 million in 2021, then grew by 6.7% to $8.7 million in 2022.
  • Business Quant data shows Total Current Liabilities for KBLB at $8.7 million in Q3 2022, $9.1 million in Q2 2022, and $8.6 million in Q1 2022.